1. Rise in Angiopoietin-2 Following Neonatal Cardiac Surgery Is Associated With Adverse Clinical Outcomes
- Author
-
Sunkyung Yu, Nicole S. Wilder, Paloma Tracy, Tammy Doman, Matthew J Orringer, Sarah B. Geisler, Kimberly J Watkins, and Mark W. Russell
- Subjects
Heart Defects, Congenital ,medicine.medical_specialty ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Critical Care and Intensive Care Medicine ,law.invention ,Angiopoietin-2 ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,law ,Serum biomarkers ,medicine ,Cardiopulmonary bypass ,Extracorporeal membrane oxygenation ,Humans ,Prospective Studies ,Renal replacement therapy ,Cardiac Surgical Procedures ,Child ,Prospective cohort study ,Stroke ,Cardiopulmonary Bypass ,business.industry ,Angiopoietin 2 ,Infant, Newborn ,030208 emergency & critical care medicine ,medicine.disease ,Cardiac surgery ,Anesthesia ,Pediatrics, Perinatology and Child Health ,cardiovascular system ,business - Abstract
OBJECTIVES Neonatal cardiac surgery for congenital cardiac defects is associated with significant morbidity and mortality, and there is a need for early identification of patients at highest risk of adverse outcomes. Because vascular endothelial injury mediates damage across organ systems, we measured serum biomarkers of endothelial injury in neonates following cardiopulmonary bypass and examined their associations with short-term outcomes. DESIGN Prospective cohort study. SETTING Pediatric cardiac ICU. PATIENTS Thirty neonates less than 2 weeks old undergoing repair of congenital cardiac defects with cardiopulmonary bypass. INTERVENTIONS None. MEASUREMENTS AND MAIN RESULTS Biomarkers of endothelial integrity, angiopoietin-1 and angiopoietin-2, were measured preoperatively and at 24 hours postoperatively. A composite adverse outcome was defined as any of the following: stroke, need for renal replacement therapy, extracorporeal membrane oxygenation support, cardiac arrest, or death. Associations of biomarkers with adverse outcomes were examined using Wilcoxon rank-sum test. There was an increase in angiopoietin-2 from preoperatively to 24 hours postoperatively (p < 0.0001) and a decrease in angiopoietin-1 from preoperatively to 24 hours postoperatively (p < 0.0001). Patients with greater rise in angiopoietin-2 from preoperatively to 24 hours postoperatively had greater risk of composite adverse outcome (p = 0.04). They had a trend toward higher Vasoactive-Inotropic Score (p = 0.06) and a higher prevalence of low cardiac output syndrome (p = 0.06). Twenty-four hour postoperative angiopoietin-2 level was associated with the composite adverse outcome (p = 0.03). The rise in angiopoietin-2 level from preoperatively to 24 hours postoperatively directly correlated with cardiopulmonary bypass duration (r = 0.47; p = 0.01). CONCLUSIONS In neonatal cardiac surgery, longer duration of cardiopulmonary bypass is directly associated with greater endothelial injury as measured by increased serum levels of angiopoietin-2. Angiopoietin-2 levels 24 hours postoperatively were significantly associated with a composite adverse outcome. Postoperative angiopoietin-2 level may serve as an early indicator of patients in need of closer monitoring and protective intervention. Further research into endothelial protective strategies is warranted.
- Published
- 2020